
    
      AZ202001 is a multicenter, double-masked, vehicle-controlled, randomized, parallel group
      study evaluating the safety, efficacy and tolerability of AZR-MD-001 ointment and AZR-MD-001
      vehicle in patients with Meibomian Gland Dysfunction (MGD)
    
  